发明名称 PHARMACEUTICAL COMPOSITION
摘要 A preparation for oral administration comprising: a pregelatinized starch comprising N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]-(1'R,2'S,3'R,4'S)-2,3-bicyclo[2,2,1]-heptanedicarboxyimide hydrochloride (lurasidone) represented by the formula (1) as an active ingredient; a water-soluble excipient; and a water-soluble polymeric binder, the preparation exhibiting an invariant level of elution behavior even when the content of its active ingredient is varied.
申请公布号 KR101380088(B1) 申请公布日期 2014.04.10
申请号 KR20077027270 申请日期 2006.05.26
申请人 发明人
分类号 A61K9/16;A61K9/20;A61K31/496;A61K47/10 主分类号 A61K9/16
代理机构 代理人
主权项
地址